Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Agnosia × Hydromorphone × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tumor Surgery 1 Pain, Postoperative 1 Liver Neoplasms 1 Breast Neoplasms 1 Agnosia 1

Interventions

Bupivacaine 5 Anesthesia, Local 5 Anesthesia, General 5 Morphine 4 Dexmedetomidine 4 Acupuncture Therapy 4 parecoxib 3 Saline Solution 3 Ropivacaine 3 Transcutaneous Electric Nerve Stimulation 2 Radiofrequency Ablation 2 Pregabalin 2 Fentanyl 2 Ethanol 2 Dental Occlusion 2 Control Groups 2 Anesthetics, Local 2 Anesthesia, Spinal 2 Anesthesia, Conduction 2 Analgesics, Opioid 2 loxoprofen 1 engage 8200 1 Yoga 1 Uterine Myomectomy 1 Transcranial Magnetic Stimulation 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Touch 1 Therapeutics 1 Telemedicine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡